407 476
[4]
Miyazato M, Yoshimura N, Chancellor MB. The other bladder syn- drome: underactive bladder. Rev Urol 2013;15:11–22.
[5]
Osman NI, Chapple CR, Abrams P, et al. Detrusor underactivity and the underactive bladder: a new clinical entity?. a review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol 2014;65:389–98.
[6]
van Koeveringe GA, Vahabi B, Andersson KE, Kirschner-Herrmans R, Oelke M. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol Urodyn 2011;30:723–8.[7]
Hoag N, Gani J. Underactive bladder: clinical features, urodynamic parameters, and treatment. Int Neurourol J 2015;19:185–9.
[8]
Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008;101:1388–95.[9]
Coyne KS, Sexton CC, Kopp Z, et al. Assessing patients’ descriptions of lower urinary tract symptoms (LUTS) and perspectives on treat- ment outcomes: results of qualitative research. Int J Clin Pract 2010;64:1260–78.
[10]
Oppenheim AN, Questionnaire Design. Interviewing and Attitude Measurement. London: Bloomsbury Publishing; 2000.[11]
Cotterill N, Norton C, Avery KNL, Abrams P, Donovan JL. A patient- centered approach to developing a comprehensive symptom and quality of life assessment of anal incontinence. Dis Colon Rectum 2008;51:82–7.[12]
Leidy NK, Wilcox TK, Jones PW, et al. Development of the EXAcerba- tions of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value Health 2010;13: 965–75.
[13] FDA. Guidance for industry: patient-reported outcome measures: use
in medical product development to support labelling claims. 2009
https://www.fda.gov/downloads/drugs/guidances/ucm193282.pdf[14]
Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007;10:S125–37.[15]
Thomas DR. A General Inductive approach for analyzing qualitative evaluation data. Am J Eval 2006;27:237–46.[16]
Glaser B, Strauss A. The constant comparative methods of qualita- tive analysisThe Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago, IL: Aldine Publishing Co; 1967. p. 101–6.[17]
Abrams P, Cardozo L, Fall M, et al. The standardisation of terminol- ogy in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003;61:37–49.[18]
Haylen BT, Maher CF, Barber MD, et al. An International Urogyne- cological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female Pelvic Organ Prolapse (POP): International Urogynecological Association (IUGA). Neu- rourol Urodyn 2016;35:137–68.[19]
Gammie A, Kaper M, Dorrepaal C, Kos T, Abrams P. Signs and symptoms of detrusor underactivity: an analysis of clinical presen- tation and urodynamic tests from a large group of patients under- going pressure flow studies. Eur Urol 2016;69:361–9.
[20]
Coyne KS, Wein AJ, Tubaro A, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int 2009;103(Suppl 3):4–11.[21]
Gannon K, Glover L, O’Neill M, Emberton M. Men and chronic illness: a qualitative study of LUTS. J Health Psychol 2004;9: 411–20.[22]
Glover L, Gannon K, McLoughlin J, Emberton M. Men’s experiences of having lower urinary tract symptoms: factors relating to bother. BJU Int 2004;94:563–7.
[23]
Wareing M. Lower urinary tract symptoms: a hermeneutic phenomenological study into men’s lived experience. J Clin Nurs 2005;14:239–46.
[24]
Drake MJ. Should nocturia not be called a lower urinary tract symptom? Eur Urol 2015;67:289–90.
[25]
Gulur DM, Mevcha AM, Drake MJ. Nocturia as a manifestation of systemic disease. BJU Int 2011;107:702–13.[26]
Hanno P, Lin A, Nordling J, et al. Bladder pain syndrome interna- tional consultation on incontinence. Neurourol Urodyn 2010;29: 191–8.E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 4 0 2 – 4 0 7
407